Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC).

Heat-labile toxins (LT) encompass at least 16 natural polymorphic toxin variants expressed by wild-type enterotoxigenic Escherichia coli (ETEC) strains isolated from human beings, but only one specific form, produced by the reference ETEC H10407 strain (LT1), has been intensively studied either as a virulence-associated factor or as a mucosal/transcutaneous adjuvant. In the present study, we carried out a biological/immunological characterization of a natural LT variant (LT2) with four polymorphic sites at the A subunit (S190L, G196D, K213E, and S224T) and one at the B subunit (T75A). The results indicated that purified LT2, in comparison with LT1, displayed similar in vitro toxic activities (adenosine 3',5'-cyclic monophosphate accumulation) on mammalian cells and in vivo immunogenicity following delivery via the oral route. Nonetheless, the LT2 variant showed increased adjuvant action to ovalbumin when delivered to mice via the transcutaneous route while antibodies raised in mice immunized with LT2 displayed enhanced affinity and neutralization activity to LT1 and LT2. Taken together, the results indicate that the two most frequent LT polymorphic forms expressed by wild ETEC strains share similar biological features, but differ with regard to their immunological properties.

[1]  M. E. Sbrogio-Almeida,et al.  Genetic Diversity of Heat-Labile Toxin Expressed by Enterotoxigenic Escherichia coli Strains Isolated from Humans , 2008, Journal of bacteriology.

[2]  Luís Carlos de Souza Ferreira,et al.  Production and release of heat-labile toxin by wild-type human-derived enterotoxigenic Escherichia coli. , 2006, FEMS immunology and medical microbiology.

[3]  A. Faruque,et al.  Enterotoxigenic Escherichia coli and Vibrio cholerae Diarrhea, Bangladesh, 2004 , 2005, Emerging infectious diseases.

[4]  F. Tzelepis,et al.  The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate. , 2004, Immunology letters.

[5]  C. Czerkinsky,et al.  Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. , 2003, Vaccine.

[6]  H. Bone,et al.  Mutant Escherichia coli Heat-Labile Toxin B Subunit That Separates Toxoid-Mediated Signaling and Immunomodulatory Action from Trafficking and Delivery Functions , 2003, Infection and Immunity.

[7]  H. Schweizer.  Vectors to express foreign genes and techniques to monitor gene expression in Pseudomonads. , 2001, Current opinion in biotechnology.

[8]  G. Dougan,et al.  Immunomodulation Using Bacterial Enterotoxins , 2001, Scandinavian journal of immunology.

[9]  Tatsuo YamamotoSQ,et al.  Primary Structure of Heat-labile Enterotoxin Produced by Escherichia coli Pathogenic for Humans * , 2001 .

[10]  L. Ferreira,et al.  Adjuvant Activity of a Nontoxic Mutant of Escherichia coli Heat-Labile Enterotoxin on Systemic and Mucosal Immune Responses Elicited against a Heterologous Antigen Carried by a LiveSalmonella enterica Serovar Typhimurium Vaccine Strain , 2000, Infection and Immunity.

[11]  C. Alving,et al.  Advances in vaccine delivery: transcutaneous immunisation. , 1999, Expert opinion on investigational drugs.

[12]  H. Weiner,et al.  Oral tolerance: mechanisms and therapeutic applications. , 1999, Advances in immunology.

[13]  T. Tsuji,et al.  A unique DNA sequence of human enterotoxigenic Escherichia coli enterotoxin encoded by chromosomal DNA. , 1997, FEMS microbiology letters.

[14]  R. Rappuoli,et al.  Probing the structure‐activity relationship of Escherichia coli LT‐A by site‐directed mutagenesis , 1994, Molecular microbiology.

[15]  T. Sixma,et al.  Intermolecular interactions between the A and B subunits of heat-labile enterotoxin from Escherichia coli promote holotoxin assembly and stability in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Spangler,et al.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. , 1992, Microbiological reviews.

[17]  F. L. Lyon,et al.  Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. , 1988, Vaccine.

[18]  B. Stoll,et al.  Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli: a prospective study. , 1985, The Journal of infectious diseases.

[19]  W. Dallas,et al.  Nucleotide sequence comparison between heat-labile toxin B-subunit cistrons from Escherichia coli of human and porcine origin , 1985, Infection and immunity.

[20]  C. Elson,et al.  Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. , 1984, Journal of immunology.

[21]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[22]  W. Dallas.  Conformity between heat-labile toxin genes from human and porcine enterotoxigenic Escherichia coli , 1983, Infection and immunity.

[23]  Y. Takeda,et al.  Molecular heterogeneity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli , 1982, Infection and immunity.

[24]  S. Gorbach,et al.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans , 1975, Infection and immunity.

[25]  S. Donta,et al.  Detection of Heat-Labile Escherichia coli Enterotoxin with the Use of Adrenal Cells in Tissue Culture , 1974, Science.